Dynamics Driving OTC Markets, NY, 2015

Regulations in the form of Basel lll, EMIR, Dodd-Frank, MiFID, IFRS and IOSCO have altered the structure of the OTC markets. This has led banks to focus on pricing and managing costs in a consistent fashion at a trade, desk and business level. These changes are not just impacting sell-side firms.

Chaired by Sivan Mahadevan, Managing Director, Morgan Stanley, the conference explored the transformations in the OTC markets driven mainly by technology, clearing and regulation.

Petal Walker, speaks about the benefits of central clearing and highlights issues pertinent to the future and effectiveness of clearing, including FCM concentration, uncleared margins and CCP risk management.

Umesh Gajria talks about central clearing requirements on OTC derivatives and how they are intended to promote overall risk management. Umesh looks at what customers are looking for, the various themes around capital efficiency, operational flexibility and customer protections.

This panel on Capital Optimization in a Complex Regulatory Environment discuss how the environment has changed since 2008 with the focus shifting from economic capital to regulatory capital and the practical challenges firms face.

Central clearing is impacting operations, valuation, and risk management for all buy-side firms. Industry practitioners explore transformations in the OTC markets, driven by technology, clearing and regulation.


  • Sivan Mahadevan, Managing Director, Morgan Stanley
  • Petal Walker, Chief Counsel, CFTC
  • Narender Rajaputhra, Executive Director, JP Morgan Chase
  • Yury Dubrovsky, Chief Risk Officer, Lazard Asset Management
  • Reade Ryan, Managing Director, BlackRock
  • John Schiavetta, SVP, AllianceBernstein
  • Umesh Gajria, Executive Director, CME Group
  • Eapen John, Director, Citigroup
  • Adam Hayes, Managing Director, Goldman Sachs
  • Dmitry Pugachevsky, Director of Research, Quantifi
  • Yi Tang, Managing Director, Wells Fargo


Innovative thinking


Dynamics Driving OTC Markets, London, 2015

Quantifi's 3rd annual risk conference, at the Vintners' Hall, London, attracted delegates from across the industry for a compelling afternoon of unique insights and discussion on 'The Dynamics Driving OTC Markets' including regulation, clearing, pricing and valuation, and risk management


Dynamics Driving OTC Markets, New York

Over 150 delegates gathered at Quantifi's annual risk conference, in New York, 2014, for unique insight on areas impacting the OTC markets, including regulatory reforms and the implications for clearing, buy-side risk management, big data in financial services and counterparty risk and regulation.


Cost of Trading and Clearing OTC Derivatives in the Wake of Margining

Recent regulations are affecting the OTC derivatives markets in complex and interrelated ways, that are changing the ways firms do business.

Let's talk!

Speak with one of our solution experts